Quantifying Low Amorphous or Crystalline Amounts of Alpha‐Lactose‐Monohydrate Using X‐Ray Powder Diffraction, Near‐Infrared Spectroscopy, and Differential Scanning Calorimetry

References

• Buckton G., Darcy P. Assessment of disorder in crystalline powders—a review of analytical techniques and their application. Int. J. Pharm. 1999; 179: 141–158
   PubMed Web of Science ®Google Scholar
• Hendrikson B. A. Characterization of calcium fenoprofen: 1. Powder dissolution rate and degree of crystallinity. Int. J. Pharm. 1990; 60: 243–252, [CROSSREF]
   Google Scholar
• Hancock B. C., Zografi G. Characteristics and significance of the amorphous state in pharmaceutical systems. J. Pharm. Sci. 1997; 86: 1–12, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Ahlneck C., Zografi G. The molecular basis of moisture effects on the physical and chemical stability of drugs in the solid state. Int. J. Pharm. 1990; 62: 87–95, [CROSSREF]
   Web of Science ®Google Scholar
• Hüttenrauch R., Fricke S., Zielke P. Mechanical activation of pharmaceutical systems. Pharm. Res. 1985; 2: 302–306, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• York P. Solid‐state properties of powders in the formulation and processing of solid dosage forms. Int. J. Pharm. 1983; 14: 1–28, [CROSSREF]
   Web of Science ®Google Scholar
• Saleki‐Gerhardt A., Ahlneck C., Zografi G. Assessment of disorder in crystalline solids. Int. J. Pharm. 1994; 101: 237–247, [CROSSREF]
   Web of Science ®Google Scholar
• Hogan S. E., Buckton G. The application of near infrared spectroscopy and dynamic vapor sorption to quantify low amorphous contents of crystalline lactose. Pharm. Res. 2001; 18: 112–116, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Pikal M. J., Lukes A. L., Lang J. E., Gaines K. Quantitative crystallinity determination for β‐lactam antibiotics by solution calorimetry: correlations with stability. J. Pharm. Sci. 1978; 67: 767–772
   PubMed Web of Science ®Google Scholar
• Gao D., Rytting J. H. Use of solution calorimetry to determine the extent of crystallinity in drugs and excipients. Int. J. Pharm. 1997; 151: 183–192, [CROSSREF]
   Google Scholar
• Briggner L., Buckton G., Bystrom K., Darcy P. The use of isothermal microcalorimetry in the study of changes in crystallinity induced during the processing of powders. Int. J. Pharm. 1994; 105: 125–135, [CROSSREF]
   Web of Science ®Google Scholar
• Bugay D. E., Newman A. W., Findlay W. P. Quantitation of cefepime*2HCl dihydrate in cefepime*2HCl monohydrate by diffuse reflectance IR and powder X‐ray diffraction techniques. J. Pharm. Biomed. Anal. 1996; 15: 49–61, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gustafsson C., Lennholm H., Iversen T., Nystrom C. Comparison of solid‐state NMR and isothermal microcalorimetry in the assessment of the amorphous component of lactose. Int. J. Pharm. 1998; 174: 243–252, [CROSSREF]
   Web of Science ®Google Scholar
• Seyer J. J., Luner P. E., Kemper M. S. Application of diffuse reflectance near‐infrared spectroscopy for determination of crystallinity. J. Pharm. Sci. 2000; 89: 1305–1316
   PubMed Web of Science ®Google Scholar
• Luner P. S., Majuru S., Kemper M. S., Seyer J. J. Quantifying crystalline form composition in binary powder mixtures using near‐infrared reflectance spectroscopy. Pharm. Dev. Technol. 2000; 5: 231–246, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Gombás A., Antal I., Szabó‐Révész P., Marton S., Eros I. Quantitative determination of crystallinity of alpha‐lactose monohydrate by near infrared spectroscopy (NIRS). Int. J. Pharm. 2003; 256: 25–32, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Taylor L. S., Zografi G. The quantitative analysis of crystallinity using FT‐Raman spectroscopy. Pharm. Res. 1998; 15: 755–761, [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chen X., Bates S., Morris K. R. Quantifying amorphous content of lactose using parallel beam X‐ray powder diffraction and whole pattern fitting. J. Pharm. Biomed. Anal. 2001; 26: 63–72, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Surana R., Suryanarayanan R. Quantitation of crystallinity in substantially amorphous pharmaceuticals and study of crystallization kinetics by X‐ray powder diffractometry. Powder Diffr. 2000; 15: 2–6
   Web of Science ®Google Scholar
• Crocker L. S., McCauley J. A. Comparison of the crystallinity of imipenem samples by X‐ray diffraction of amorphous material. J. Pharm. Sci. 1995; 84: 226–227
   PubMed Web of Science ®Google Scholar
• Nakai Y., Fukuoka E., Nakajima S.‐I., Morita M. Physicochemical properties of crystalline lactose I. Estimation of the degree of crystallinity and the disorder parameter by an X‐ray diffraction method. Chem. Pharm. Bull. 1982; 30: 1811–1818, [CSA]
   Web of Science ®Google Scholar
• Riepma K. A., Decker B. G., Lerk C. F. The effect of moisture sorption on the strength and internal surface area of lactose tablets. Int. J. Pharm. 1992; 87: 149–159, [CROSSREF]
   Google Scholar
• Shulka A. J., Price J. C. Effect of moisture content on compression properties of directly compressible high beta‐content anhydrous lactose. Drug Dev. Ind. Pharm. 1991; 17: 2067–2081
   Web of Science ®Google Scholar
• Buckton G., Yonemochi E., Hammond J., Moffat A. The use of near infra‐red spectroscopy to detect changes in the form of amorphous and crystalline lactose. Int. J. Pharm. 1998; 168: 231–241, [CROSSREF]
   Web of Science ®Google Scholar
• The Unscrambler® User Manual. CAMO ASA. 1998
   Google Scholar
• Joupilla K., Kansikas J., Roos Y. H. Crystallization and X‐ray diffraction of crystals formed in water‐plasticized amorphous lactose. Biotech. Progr. 1998; 14: 347–350, [CSA], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Martens H., Naes T. Methods for calibration. Multivariate Calibration. John Wiley & Sons Ltd., Great Britain 1991; 116–163
   Google Scholar
• Guinot S., Leveiller F. The use of MTDSC to assess the amorphous phase content of a micronised drug substance. Int. J. Pharm. 1999; 192: 63–75, [CROSSREF]
   PubMed Web of Science ®Google Scholar